Audencel is a dendritic cell (DC)-based cellular cancer immunotherapy against glioblastoma multiforme (GBM). It is characterized by loading of DCs with autologous whole tumor lysate and in vitro maturation via…

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...